Basilea Announces Health Canada Approves ZEVTERA to Treat Bacterial Lung Infections

By: via Benzinga
Basilea Pharmaceutica Ltd. (OTC: BPMUF) announced today that Health Canada has approved ZEVTERA (ceftobiprole medocaril) for the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.